Xarator | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Xarator
Annual Reports

PharmaCompass Sponsored Ads

Contact Supplier

Egis Atorvastatin - Dapagliflozin

Contact Supplier

pharmacompass-1-m-2025-08-25

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Xarator

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

206 API Suppliers, 65 USDMF, 43 CEP/COS, 20 JDMF, 42 EU WC, 87 KDMF, 26 NDC API, 73 Listed Suppliers, $ API Reference Price

206 API Suppliers
65 USDMF
43 CEP/COS
20 JDMF
42 EU WC
87 KDMF
26 NDC API
73 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

229 Drugs in Development

229 Drugs in Development

INTERMEDIATES

26 Intermediate Suppliers

26 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1606 FDF Dossiers, 198 FDA Orange Book, 790 Europe, 108 Canada, 75 Australia, 70 South Africa, 365 Listed Dossiers

1606 FDF Dossiers
198 FDA Orange Book
790 Europe
108 Canada
75 Australia
70 South Africa
365 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 20MG BASE, TABLET;ORAL - EQ 40MG BASE, TABLET;ORAL - EQ 80MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE, TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

TABLET;ORAL - EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE
TABLET;ORAL - EQ 20MG BASE
TABLET;ORAL - EQ 40MG BASE
TABLET;ORAL - EQ 80MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 10MG BASE;EQ 80MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 2.5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 10MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 20MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 40MG BASE
TABLET;ORAL - EQ 5MG BASE;EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 5 Evonik, 3 Rochem International Inc, 23 SPI Pharma, 18 DKSH, 1 Pharm-RX Chemical, 2 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 2 Kewpie Corporation, 5 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 3 Pfanstiehl, 4 Kirsch Pharma, 1 ACG Worldwide, 7 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 18 BASF, 1 BioSpectra, 1 CD Formulation, 12 Corel Pharma Chem, 7 DFE Pharma, 1 Esteem Industries, 1 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

75 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 43 Direct Compression, 35 Thickeners and Stabilizers, 34 Disintegrants & Superdisintegrants, 29 Granulation, 27 Taste Masking, 26 Controlled & Modified Release, 24 Solubilizers, 22 Parenteral, 22 Lubricants & Glidants, 21 Chewable & Orodispersible Aids, 20 Topical, 19 Film Formers & Plasticizers, 14 Rheology Modifiers, 13 Co-Processed Excipients, 11 Emulsifying Agents, 9 API Stability Enhancers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents

75 Fillers, Diluents & Binders
53 Coating Systems & Additives
43 Direct Compression
35 Thickeners and Stabilizers
34 Disintegrants & Superdisintegrants
29 Granulation
27 Taste Masking
26 Controlled & Modified Release
24 Solubilizers
22 Parenteral
22 Lubricants & Glidants
21 Chewable & Orodispersible Aids
20 Topical
19 Film Formers & Plasticizers
14 Rheology Modifiers
13 Co-Processed Excipients
11 Emulsifying Agents
9 API Stability Enhancers
5 Empty Capsules
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
4 Coloring Agents

DIGITAL CONTENT

155 News #PharmaBuzz

155 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 662 Regulatory FDF Prices, 51 Annual Reports

39 US Medicaid Prescriptions
662 Regulatory FDF Prices
51 Annual Reports

MARKET PLACE

59 APIs, 21 FDF Dossiers, 1 Intermediates

59 APIs
21 FDF Dossiers
1 Intermediates

PATENTS & EXCLUSIVITIES

6 US Patents, 224 Health Canada Patents

6 US Patents
224 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 EDQM, 9 USP, 4 JP, 20 Others

6 EDQM
9 USP
4 JP
20 Others

ANALYTICAL

5 BioAnalytical Methods

5 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 184 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

51 All

01 8Atozet

02 1Caduet

03 4Gadavist/Gadovist

04 2Gadovist product family

05 16Lipitor

06 3Nilemdo/Nustendi

07 2Rosuzet

08 5Vytorin

09 9Zetia

10 1ZetiaTM

List of Suppliers

Product Main Page

01

Brand Name : Lipitor

Atorvastatin Calcium

Peptide Process CMC

Not Confirmed

Brand Name : Lipitor

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin Calcium

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 100

2019 Revenue in Millions : 121

Growth (%) : -17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Lipitor

Atorvastatin Calcium

Peptide Process CMC

Not Confirmed

Brand Name : Lipitor

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Pfizer Inc.

Atorvastatin Calcium

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2019 Revenue in Millions : 1,973

2018 Revenue in Millions : 2,062

Growth (%) : -4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Gadovist product family

Atorvastatin, Ezetimibe

Peptide Process CMC

Not Confirmed

Brand Name : Gadovist product family

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 466

2019 Revenue in Millions : 524

Growth (%) : -11

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Zetia

Atorvastatin, Ezetimibe

Peptide Process CMC

Not Confirmed

Brand Name : Zetia

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 482

2019 Revenue in Millions : 590

Growth (%) : -18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Atozet

Atorvastatin, Ezetimibe

Peptide Process CMC

Not Confirmed

Brand Name : Atozet

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 453

2019 Revenue in Millions : 391

Growth (%) : 16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Vytorin

Atorvastatin, Ezetimibe

Peptide Process CMC

Not Confirmed

Brand Name : Vytorin

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2020 Revenue in Millions : 183

2019 Revenue in Millions : 285

Growth (%) : -36

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Lipitor

Atorvastatin Calcium

Peptide Process CMC

Not Confirmed

Brand Name : Lipitor

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin Calcium

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 19

2020 Revenue in Millions : 99

Growth (%) : -80

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Gadovist product family

Atorvastatin, Ezetimibe

Peptide Process CMC

Not Confirmed

Brand Name : Gadovist product family

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 460

2020 Revenue in Millions : 466

Growth (%) : 9

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Vytorin

Atorvastatin, Ezetimibe

Peptide Process CMC

Not Confirmed

Brand Name : Vytorin

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 164

2020 Revenue in Millions : 182

Growth (%) : -10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Zetia

Atorvastatin, Ezetimibe

Peptide Process CMC

Not Confirmed

Brand Name : Zetia

Peptide Process CMC

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Atorvastatin, Ezetimibe

Main Therapeutic Indication : Cardiovascular Diseases

Currency : USD

2021 Revenue in Millions : 378

2020 Revenue in Millions : 482

Growth (%) : -22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!